These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 5921429

  • 1. Hypercalcemia in patients with advanced mammary cancer and osseous metastases. Effect of hormone therapy and schedule of treatment.
    Donovan AJ, Bethune JE, Berne TV.
    Am Surg; 1966 Oct; 32(10):673-80. PubMed ID: 5921429
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Acute tubular nephropathy and late radiologic vacular calcifications following treatment of a hypercalcemia with intravenous administration of phosphates].
    Bernheim C, Vischer T.
    Schweiz Med Wochenschr; 1968 Apr 27; 98(17):641-5. PubMed ID: 5683348
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy of advanced mammary carcinomas with high-dosed cytostatics].
    Boeckl O, Heitz N, Wasl H, Karrer K, Mannheimer E.
    Munch Med Wochenschr; 1965 Oct 22; 107(43):2114-8. PubMed ID: 5899028
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rapid estrogen-induced hypercalcemia.
    Swaroop S, Krant MJ.
    JAMA; 1973 Feb 19; 223(8):913-4. PubMed ID: 4739237
    [No Abstract] [Full Text] [Related]

  • 10. Tamoxifen-induced hypercalcemia in metastatic breast cancer.
    Nemoto T, Rosner DH, Patel DJ, Wettingfeld RF, Bambrah SS, Dao TL.
    N Y State J Med; 1980 Dec 19; 80(13):1980-2. PubMed ID: 6937756
    [No Abstract] [Full Text] [Related]

  • 11. [Endolumbar administration of hydrocortisone in the complex treatment of patients with generalized breast cancer].
    Pankov AK, Mindlin SS, Verkhovtseva AI.
    Vopr Onkol; 1975 Dec 19; 21(5):99-104. PubMed ID: 1243210
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hypercalcemia in breast cancer].
    Okada Y, Ogawa M, Horikoshi N, Inagaki J, Inoue K, Ikeda K, Usui N, Nakada H, Adachi K, Mukaiyama T.
    Gan To Kagaku Ryoho; 1984 Jul 19; 11(7):1468-74. PubMed ID: 6742868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases].
    Sueyoshi K, Ogura Y, Komori T, Takahashi M, Tian TX, Tatsumi T, Matsuki M, Saika Y, Uesugi Y, Utsunomiya K, Inomata Y, Narabayashi I.
    Gan To Kagaku Ryoho; 2002 Oct 19; 29(10):1795-9. PubMed ID: 12402432
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I, Kousidou OCh, Karamanos NK.
    In Vivo; 2005 Oct 19; 19(1):311-8. PubMed ID: 15796191
    [Abstract] [Full Text] [Related]

  • 20. A comparison of bone-related biomarkers and CA27.29 to assess response to treatment of osseous metastatic breast cancer.
    Lüfter D, Richter A, Günther S, Flath B, Akrivakis C, Geppert R, Wernecke KD, Possinger K.
    Anticancer Res; 2000 Oct 19; 20(6D):5099-105. PubMed ID: 11326676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.